Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06313606

Sparking Gut Bacteria Production of Bioactive Xenolipids in Situ

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Long-chain cyclopropane fatty acids (CpFAs) are microbially-derived lipids (fats), some of which can be found in select foods and appear to be produced naturally in the gut from dietary fatty acid precursors. Some of these lipids appear to have signaling properties in the body's tissues, i.e., to help regulate cardiometabolic health. Thus, increasing the bioavailability of CpFAs in humans may have utility to improve management of blood sugar and blood lipids, or to mitigate or prevent non-alcoholic fatty liver disease (NAFLD). This study is a proof-of-principle experiment in 10 subjects, to feed dietary fats thought to enhance upper gut CpFA production. The latter will be monitored through post-meal blood and urine CpFA concentration measurements, as well as concentration in the stool.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary fat positive controlDietary fat-containing meal plan with a specific supplement that may modify fat metabolism
DIETARY_SUPPLEMENTDietary fat negative controlDietary fat-containing meal plan with a specific supplement that should not modify fat metabolism

Timeline

Start date
2024-04-01
Primary completion
2025-05-31
Completion
2025-05-31
First posted
2024-03-15
Last updated
2024-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06313606. Inclusion in this directory is not an endorsement.